The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular weight-loss drugs like Ozempic and Zepbound.

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. | In the letters sent to 30 different telehealth companies that market compounded versions of ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

As GLP-1 adoption accelerates, food and beverage brands face structural shifts in consumption  and strategic decisions on how to communicate them on pack.

The cuts aim to make the drugs more accessible to insured patients, particularly people with high-deductible health plans or ...

GLP-1 medications can be effective for weight loss and diabetes management but require lifestyle changes and can have severe side effects. Hear from users and their stories behind the medications.

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

GoodRx reports that GLP-1 medications will expand in use and accessibility, with new oral options and evolving insurance ...

Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple substances. Compared with the other medications, people taking the GLP-1 drugs ...

KUALA LUMPUR, Feb 10 — Often referred to as a ‘miracle drug’, glucagon-like peptide-1 (GLP-1) medications have seen a surge in popularity in recent years, fuelled by social media testimonials, ...

Duane Ford has managed budgets for the Bow and Dunbarton school districts for more than a decade, but nothing quite prepared him for this year’s health insurance bill: a 16% jump in premiums, the ...